Transarterial chemoembolization combined with immunotherapy and targeted therapy as first-line treatment for unresectable and non-metastatic hepatocellular carcinoma: a meta-analysis of phase III trials. [PDF]
Wang L, Luo B, Zhao M, Shen J.
europepmc +1 more source
The Clinical Impact of Cardiovascular Thrombosis on Overall Survival in Patients With Hepatocellular Carcinoma After Transarterial Chemoembolization. [PDF]
Fujita K +7 more
europepmc +1 more source
Long-Term Outcomes of Transarterial Chemoembolization for Intrahepatic Cholangiocarcinoma: Overall Survival and Tumor Response. [PDF]
Vogl TJ +5 more
europepmc +1 more source
Combining Transarterial Chemoembolization with Sorafenib Improves Survival in Selected Patients with Hepatocellular Carcinoma and Extrahepatic Spread: A Multicenter Real-World Study. [PDF]
Yuan Y +11 more
europepmc +1 more source
Diagnosis and Treatment Report of a Case of Small Hepatocellular Carcinoma With Left Adrenal Metastasis and Hemorrhage in an Elderly Male Hepatitis B Virus Carrier. [PDF]
Zhou G, Wu F, Feng T, Lin T.
europepmc +1 more source
Extent of Embolization as an Independent Prognostic Factor in Superselective Conventional Transarterial Chemoembolization for Hepatocellular Carcinoma. [PDF]
Okumura K +6 more
europepmc +1 more source
Efficacy and safety of tyrosine kinase inhibitors combined with sintilimab and transarterial chemoembolization in patients with Barcelona Clinic Liver Cancer stage B/C hepatocellular carcinoma: a pooled analysis. [PDF]
Lu GL +4 more
europepmc +1 more source
Efficacy and safety of DEB-TACE combined with HAIC and donafenib in the treatment of unresectable hepatocellular carcinoma: a dual-center retrospective study. [PDF]
Zhang X +8 more
europepmc +1 more source
Efficacy and safety of sintilimab plus a bevacizumab biosimilar combined with transarterial chemoembolization for advanced hepatocellular carcinoma. [PDF]
Yang J, Xu Q, Wu S.
europepmc +1 more source

